摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2-methoxyphenyl)-2-[4-(pyridin-2-yl)piperazin-1-yl]acetamide

中文名称
——
中文别名
——
英文名称
N-(2-methoxyphenyl)-2-[4-(pyridin-2-yl)piperazin-1-yl]acetamide
英文别名
N-(2-methoxyphenyl)-2-(4-pyridin-2-ylpiperazin-1-yl)acetamide
N-(2-methoxyphenyl)-2-[4-(pyridin-2-yl)piperazin-1-yl]acetamide化学式
CAS
——
化学式
C18H22N4O2
mdl
MFCD05147200
分子量
326.4
InChiKey
DGDPIUHYQDINOZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    24
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    57.7
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS
    申请人:Bristol-Myers Squibb Pharma Company
    公开号:EP1417177A2
    公开(公告)日:2004-05-12
  • EP1417177A4
    申请人:——
    公开号:EP1417177A4
    公开(公告)日:2005-10-19
  • [EN] ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS<br/>[FR] ACYLSEMICARBAZIDES INHIBITEURS DE KINASE DEPENDANT DE LA CYCLINE UTILES EN TANT QU'AGENTS ANTICANCEREUX ET ANTIPROLIFERATIFS
    申请人:BRISTOL MYERS SQUIBB PHARMA CO
    公开号:WO2003007883A2
    公开(公告)日:2003-01-30
    The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I) that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and their regulatory subunits know as cyclins A-G. This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.
查看更多